<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Adastra Holdings Ltd — News on 6ix</title>
    <link>https://6ix.com/company/phyto-extractions-inc</link>
    <description>Latest news and press releases for Adastra Holdings Ltd on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 29 Apr 2026 20:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/phyto-extractions-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6836845f78dffbe2df169a8e.webp</url>
      <title>Adastra Holdings Ltd</title>
      <link>https://6ix.com/company/phyto-extractions-inc</link>
    </image>
    <item>
      <title>Adastra Holdings Announces Resignation of Director</title>
      <link>https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-announces-resignation-of-director</link>
      <guid isPermaLink="true">https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-announces-resignation-of-director</guid>
      <pubDate>Wed, 29 Apr 2026 20:00:00 GMT</pubDate>
      <description>Langley, British Columbia--(Newsfile Corp. - April 29, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (&quot;Adastra&quot; or the &quot;Company&quot;), a leading cannabis processor and producer of two top Canadian concentrates brands with a focus on product innovation and commercialization for adult-use and medical markets, announces today that Paul Morgan has tendered his resignation as a director of the Company effective as of April 28, 2026. The Company thanks Mr. Morgan for his service as a member of the</description>
    </item>
    <item>
      <title>Lifeist Announces Leadership Changes</title>
      <link>https://6ix.com/company/phyto-extractions-inc/news/lifeist-announces-leadership-changes-2</link>
      <guid isPermaLink="true">https://6ix.com/company/phyto-extractions-inc/news/lifeist-announces-leadership-changes-2</guid>
      <pubDate>Tue, 31 Mar 2026 01:15:00 GMT</pubDate>
      <description>Lifeist Wellness Inc. (&quot;Lifeist&quot; or the &quot;Company&quot;) (TSXV: LFST) (FRANKFURT: M5B0) (OTCQB: LFSWF), a health and wellness company focused on building top wellness brands, announces changes to its board of directors.</description>
    </item>
    <item>
      <title>Adastra Holdings Announces Agreement to Sell Assets and Resignation of Director</title>
      <link>https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-announces-agreement-to-sell-assets-and-resignation-of-director</link>
      <guid isPermaLink="true">https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-announces-agreement-to-sell-assets-and-resignation-of-director</guid>
      <pubDate>Mon, 02 Mar 2026 13:30:00 GMT</pubDate>
      <description>Langley, British Columbia--(Newsfile Corp. - March 2, 2026) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (&quot;Adastra&quot; or the &quot;Company&quot;) announces that Adastra Labs Inc. (&quot;Adastra Labs&quot;), a wholly-owned subsidiary of the Company, has entered into an asset purchase agreement dated February 27, 2026 with an arm&apos;s length purchaser (the &quot;Purchaser&quot;), pursuant to which Adastra Labs has agreed to sell certain cryoethanol and hydrocarbon extraction and processing equipment as well as packaging and...</description>
    </item>
    <item>
      <title>Adastra Holdings Announces Completion of Sale of Subsidiaries</title>
      <link>https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-announces-completion-sale-225700198</link>
      <guid isPermaLink="true">https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-announces-completion-sale-225700198</guid>
      <pubDate>Wed, 15 Oct 2025 22:57:00 GMT</pubDate>
      <description>Langley, British Columbia--(Newsfile Corp. - October 15, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the &quot;Company&quot;) announces that it has completed the sale of all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. (&quot;Adastra Labs&quot;), 1178562 B.C. Ltd. (&quot;1178562&quot;), and Adastra Brands Inc. (&quot;Adastra Brands&quot;), to 1538634 B.C. Ltd. (the &quot;Purchaser&quot;).The aggregate consideration for all transactions was $4,000,000, including $495,000 for.</description>
    </item>
    <item>
      <title>Adastra Holdings Enters into Agreements to Sell Subsidiaries</title>
      <link>https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-enters-agreements-sell-032800566</link>
      <guid isPermaLink="true">https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-enters-agreements-sell-032800566</guid>
      <pubDate>Thu, 09 Oct 2025 03:28:00 GMT</pubDate>
      <description>Langley, British Columbia--(Newsfile Corp. - October 8, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2E0) (the &quot;Company&quot;) announces that it has entered into agreements to sell all of the issued and outstanding shares of its wholly-owned subsidiaries, Adastra Labs Holdings (2019) Ltd. (&quot;Adastra Labs&quot;), 1178562 B.C. Ltd. (&quot;1178562&quot;), and Adastra Brands Inc. (&quot;Adastra Brands&quot;). The aggregate consideration for all transactions is $4,000,000, including $495,000 for the sale of Adastra Labs...</description>
    </item>
    <item>
      <title>Adastra Holdings Announces New Director</title>
      <link>https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-announces-director-130000730</link>
      <guid isPermaLink="true">https://6ix.com/company/phyto-extractions-inc/news/adastra-holdings-announces-director-130000730</guid>
      <pubDate>Mon, 03 Mar 2025 13:00:00 GMT</pubDate>
      <description>Langley, British Columbia--(Newsfile Corp. - March 3, 2025) - Adastra Holdings Ltd. (CSE: XTRX) (FSE: D2EP) (&quot;Adastra&quot; or the &quot;Company&quot;), a leading cannabis processor and producer of two top Canadian concentrates brands with a focus on product innovation and commercialization for adult-use and medical markets, is pleased to announce the appointment of Mark Qvist as a member of its board of directors, effective February 28, 2025. Mr. Qvist has over 25 years of experience ...</description>
    </item>
  </channel>
</rss>